Back to search results

Study on Proton Radiotherapy of Thymic Malignancies

Abroad (travel likely)Recruiting

Conditions

Cardiotoxicity · Pulmonary Toxicity · Thymus Neoplasms

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Department of Oncology, Norrlands Universitetssjukhus, Umeå, Norrland, Sweden

    Contact: Study coordinator (Mikael Johansson, MD PhD) · mikael.johansson@onkologi.umu.se · 0046703711414
    Contact: Study coordinator (Per Bergström, MD PhD) · per.bergstrom@vll.se
    Contact: Principal Investigator (Mikael Johansson, MD PhD)
    Per Bergström, MD (Sub-investigator)

  • Department of Oncology, Karolinska University Hospital, Stockholm, Stockholm County, Sweden

    Contact: Study coordinator (Signe Friesland, MD PhD) · signe.friesland@sll.se
    Contact: Study coordinator (Michael Gubanski, MD PhD) · michael.gubanski@sll.se
    Contact: Principal Investigator (Signe Friesland, MD PhD)
    Michael Gubanski, MD PhD (Sub-investigator)

  • Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Västra Götaland County, Sweden

    Contact: Study coordinator (Jan Nyman, Ass prof) · jan.nyman@oncology.gu.se · 0046313427927
    Contact: Study coordinator (Andreas Hallqvist, MD, PhD) · andreas.hallqvist@vgregion.se · +46739845114
    Andreas Hallqvist, MD PhD (Sub-investigator)
    Annica Ravn-Fischer, MD phD (Sub-investigator)
    Hillevi Rylander, MD (Sub-investigator)
    Anna Bäck, PhD (Sub-investigator)
    Erik Lundin, MD (Sub-investigator)
    Jens Engleson, MD (Sub-investigator)
    Contact: Principal Investigator (Jan Nyman, Ass prof)
Study leads

  • Hillevi Rylander, MD

    Study Director

    Head of Skandion Clinic

View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)